Research Article

Antibacterial Properties of Carvacrol against Antibiotic-Resistant Bacteria, Enteric Bacteria, and Oral Pathogens

Volume: 27 Number: 4 June 28, 2025

Antibacterial Properties of Carvacrol against Antibiotic-Resistant Bacteria, Enteric Bacteria, and Oral Pathogens

Abstract

The present study investigated the antibacterial activity of carvacrol against Vancomycin-Resistant Enterococci (VRE), Carbapenem-Resistant Enterobacteriaceae (CRE), Methicillin-Resistant Staphylococcus aureus (MRSA), Escherichia coli ATCC 8739, Enterococcus faecalis ATCC 29212, Streptococcus mitis, Streptococcus mutans CNCTC 8/77 and Streptococcus salivarius CNCTC 64/59. According to the results of the disc diffusion method, carvacrol has extremely high antibacterial activity with zones of 28 mm, 38 mm, 39 mm, 36 mm, 50 mm, 41 mm, 47 mm, and 39 mm against E. coli, E. faecalis, VRE, CRE, S. salivarius, S. mutans, MRSA, S. mitis, respectively. In the present study, the Minimum Inhibition Concentration (MIC) was also investigated by using the Broth Microdilution method. Carvacrol has MIC of 7.62 mg/mL against E. coli, 15.25 mg/mL against VRE, 30.5 mg/mL against E. faecalis, CRE, and S. salivarius, 61 mg/mL against S. mutans, 1.90 mg/mL against MRSA and S. mitis. Carvacrol is a very strong antimicrobial agent and may be used in important applications in the food and pharmaceutical industry. It may also be a good candidate for developing alternative treatments. The results of the present study may be beneficial for further studies with this antibacterial agent for both academia and industry.

Keywords

References

  1. [1] Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S, Cohen J, Findlay D, Gyssens I, Heure OE, Kahlmeter G, Kruse H, Laxminarayan R, Liébana E, López-Cerero L, Macgowan A, Martins M, Rodríguez-Baño J, Rolain J-M, Segovia C, Sigauque B, Tacconelli E, Wellington E, Vila J. The global threat of antimicrobial resistance: science for intervention. New Microbe and New Infect. 2015; 6: 22-29. https://doi.org/10.1016/j.nmni.2015.02.007.
  2. [2] Oliveira AS, Llanes L C, Brighente IMC, Nunes RJ, Yunes RA, Máximo Jr N, Baumgart AMK, Aust AN, Cruz AB. New sulfonamides derived from carvacrol: compounds with high antibacterial activity against resistant Staphylococcus aureus strains. J Biosci Med. 2016; 4(7): 105-114. https://doi.org/10.4236/jbm.2016.47011.
  3. [3] Frieri M, Kumar K, Boutin A. Antibiotic resistance. J Infect Public Health. 2017; 10(4): 369-378. https://doi.org/10.1016/j.jiph.2016.08.007.
  4. [4] Priyadharsini RP. Antibiotic resistance: What is there in past, present and future?. J Young Pharm. 2019; 11(4): 333-336. https://doi.org/10.5530/jyp.2019.11.69.
  5. [5] Zaman SB, Hussain MA, Nye R, Mehta V, Mamun KT, Hossain NA. Review on antibiotic resistance: Alarm bells are ringing. Cureus. 2017; 9 (6): e1403. https://doi.org/10.7759/cureus.1403.
  6. [6] Zhang D, Gan R-Y, Ge Y-Y, Yang Q-Q, Ge J, Li H-B, Corke H. Research progress on the antibacterial mechanisms of carvacrol: A mini review. Bioact Compd Health Dis. 2018; 1(6): 71-81. https://doi.org/10.31989/bchd.v1i6.551.
  7. [7] Arfa AB, Combes S, Preziosi-Belloy L, Gontard N, Chalier P. Antimicrobial activity of carvacrol related to its chemical structure. Lett Appl Microbiol. 2006; 43(2): 149-154. https://doi.org/10.1111/j.1472-765X.2006.01938.x.
  8. [8] Sharifi‐Rad M, Varoni EM, Iriti M, Martorell M, Setzer WN, Contreras MM, Salehi B, Soltani‐Nejad A, Rajabi S, Tajbakhsh M, Sharifi‐Rad J. Carvacrol and human health: A comprehensive review. Phytother Res. 2018; 32(9): 1675-1687. https://doi.org/10.1002/ptr.6103.

Details

Primary Language

English

Subjects

Pharmaceutical Microbiology

Journal Section

Research Article

Publication Date

June 28, 2025

Submission Date

February 17, 2023

Acceptance Date

April 4, 2023

Published in Issue

Year 2023 Volume: 27 Number: 4

APA
Hoş, A., Omurtag Özgen, P. S., İnci, A., Avcı, B., & Ceylan, C. (2025). Antibacterial Properties of Carvacrol against Antibiotic-Resistant Bacteria, Enteric Bacteria, and Oral Pathogens. Journal of Research in Pharmacy, 27(4), 1380-1387. https://izlik.org/JA64SY26BS
AMA
1.Hoş A, Omurtag Özgen PS, İnci A, Avcı B, Ceylan C. Antibacterial Properties of Carvacrol against Antibiotic-Resistant Bacteria, Enteric Bacteria, and Oral Pathogens. J. Res. Pharm. 2025;27(4):1380-1387. https://izlik.org/JA64SY26BS
Chicago
Hoş, Ayşegül, Pınar Sinem Omurtag Özgen, Ayşe İnci, Buse Avcı, and Ceyda Ceylan. 2025. “Antibacterial Properties of Carvacrol Against Antibiotic-Resistant Bacteria, Enteric Bacteria, and Oral Pathogens”. Journal of Research in Pharmacy 27 (4): 1380-87. https://izlik.org/JA64SY26BS.
EndNote
Hoş A, Omurtag Özgen PS, İnci A, Avcı B, Ceylan C (July 1, 2025) Antibacterial Properties of Carvacrol against Antibiotic-Resistant Bacteria, Enteric Bacteria, and Oral Pathogens. Journal of Research in Pharmacy 27 4 1380–1387.
IEEE
[1]A. Hoş, P. S. Omurtag Özgen, A. İnci, B. Avcı, and C. Ceylan, “Antibacterial Properties of Carvacrol against Antibiotic-Resistant Bacteria, Enteric Bacteria, and Oral Pathogens”, J. Res. Pharm., vol. 27, no. 4, pp. 1380–1387, July 2025, [Online]. Available: https://izlik.org/JA64SY26BS
ISNAD
Hoş, Ayşegül - Omurtag Özgen, Pınar Sinem - İnci, Ayşe - Avcı, Buse - Ceylan, Ceyda. “Antibacterial Properties of Carvacrol Against Antibiotic-Resistant Bacteria, Enteric Bacteria, and Oral Pathogens”. Journal of Research in Pharmacy 27/4 (July 1, 2025): 1380-1387. https://izlik.org/JA64SY26BS.
JAMA
1.Hoş A, Omurtag Özgen PS, İnci A, Avcı B, Ceylan C. Antibacterial Properties of Carvacrol against Antibiotic-Resistant Bacteria, Enteric Bacteria, and Oral Pathogens. J. Res. Pharm. 2025;27:1380–1387.
MLA
Hoş, Ayşegül, et al. “Antibacterial Properties of Carvacrol Against Antibiotic-Resistant Bacteria, Enteric Bacteria, and Oral Pathogens”. Journal of Research in Pharmacy, vol. 27, no. 4, July 2025, pp. 1380-7, https://izlik.org/JA64SY26BS.
Vancouver
1.Ayşegül Hoş, Pınar Sinem Omurtag Özgen, Ayşe İnci, Buse Avcı, Ceyda Ceylan. Antibacterial Properties of Carvacrol against Antibiotic-Resistant Bacteria, Enteric Bacteria, and Oral Pathogens. J. Res. Pharm. [Internet]. 2025 Jul. 1;27(4):1380-7. Available from: https://izlik.org/JA64SY26BS